24 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
1795
Lotus Pharmaceutical
NT$257.00-2.5%-7.1%NT$68.5bNT$394.60PE15.7xE21.6%1.8%
4114
Synmosa Biopharma
NT$33.05-2.2%-3.1%NT$13.9bNT$36.00PE19.3xS12.7%1.7%
6785
Alar Pharmaceuticals
NT$125.00-2.7%-47.9%NT$8.4bNT$290.00PE20.8xS-133.2%1.2%
6472
Bora Pharmaceuticals
NT$818.001.5%22.8%NT$81.7bNT$977.83PE21.7xE16.2%1.5%
1720
Standard Chemical & Pharmaceutical
NT$61.00-0.8%-4.8%NT$10.9bn/aPE12.9xn/a4.4%
8432
TSH Biopharm
NT$59.100.2%16.1%NT$2.3bn/aPE19xn/a2.2%
6817
Winston Medical Supply
NT$90.60-0.1%-7.4%NT$1.7bn/aPE11.1xn/a7.3%
6848
RBC Bioscience
NT$18.85-0.3%23.6%NT$244.6mn/aPE14.2xn/a5.9%
3705
YungShin Global Holding
NT$52.800.4%13.3%NT$13.9bn/aPE13.7xn/a4.4%
1701
Cenra
NT$21.150%-8.8%NT$6.0bn/aPE16.2xn/an/a
1780
Allied Biotech
NT$17.502.9%10.8%NT$1.7bn/aPE15.9xn/a4.9%
1734
Sinphar PharmaceuticalLtd
NT$30.750.5%0.9%NT$5.6bNT$31.00PE16.7xS5.4%3.0%
3716
Cenra
NT$37.100.7%n/aNT$5.5bn/aPE14.8xn/a0%
6986
HeXun Biosciences
NT$70.50-1.1%12.8%NT$3.2bn/aPE26.1xn/an/a
1783
Maxigen Biotech
NT$51.80-0.6%14.1%NT$4.6bn/aPE29.7xn/a1.9%
4160
Genetics Generation Advancement
NT$67.10-0.6%69.1%NT$1.8bn/aPE30.6xn/a0.7%
6547
New
Medigen Vaccine Biologics
NT$50.001.4%-20.6%NT$16.4bNT$102.00PS25.4xE198.9%n/a
6919
Caliway Biopharmaceuticals
NT$703.0012.3%237.2%NT$103.6bNT$750.00PS2158.3xE-14.5%n/a
6446
New
PharmaEssentia
NT$696.00-3.3%115.8%NT$230.7bNT$854.80PE125.5xE71.8%n/a
6539
DV Biomed
NT$61.504.1%-56.4%NT$1.3bn/aPE24.1xn/a3.3%
4102
Yung Zip Chemical Ind
NT$31.102.8%-21.1%NT$1.3bn/aPE15.2xn/a2.6%
4142
New
Adimmune
NT$21.70-8.4%-30.2%NT$9.3bNT$23.00PS5.8xS4.3%0%
4746
Formosa Laboratories
NT$71.40-1.0%-37.6%NT$8.6bNT$117.50PE21.9xS7.8%2.8%
6620
Handa Pharmaceuticals
NT$78.0011.1%-55.6%NT$11.0bNT$200.00PE24.3xn/a1.3%
Page 1 of 1